RI-MUHC

A key to unlocking the mystery of triple negative breast cancer

A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patients and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival was prolonged in patients who expressed the prolactin receptor and that prolactin hormone was able to reduce the aggressive behavior of cancerous cells. It does so by decreasing their ability to divide and form new tumors.

Published: 25Oct2016

A ‘tropical’ parasitic disease emerges in the Arctic

By Julie Robert, McGill University Health Centre

Canadian researchers describe the first outbreak of Cryptosporidium parasite in Nunavik

Published: 28Apr2016

The brain gives up more secrets

By Julie Robert, McGill University Health Centre

A research team, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, has broken new ground in our understanding of the complex functioning of the brain.

Published: 18Feb2016

Breakthrough in fight against muscle wasting diseases

It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre (RI-MUHC) and University of Alberta could be a game changer for patients, improving both quality of life and longevity. The research team discovered a new gene involved in muscle wasting that could be a good target for drug development.

Published: 15Sep2015

Gestational diabetes: A diabetes predictor in fathers

In a large study analyzing 20 years of data from Quebec, a team from the Research Institute of the McGill University Health Centre (RI-MUHC) has demonstrated that gestational diabetes signals future diabetes risk not only in mothers, but also in fathers. The study was recently published in Diabetes Care.

Published: 13Aug2015

Pages